About this trial
This randomized controlled trial aims to evaluate the effect of early pre-induction norepinephrine infusion on perioperative hemodynamic stability in septic patients with SOFA score ≥2 undergoing surgery under general anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
- Age 18 to 65 years
Diagnosed with severe sepsis with SOFA score ≥2
Scheduled for surgery under general anesthesia
ASA physical status III or IV
Disqualifiers
Severe pre-existing cardiovascular compromise
Known allergy or hypersensitivity to norepinephrine
Pregnancy or lactation
Refusal to participate
Trial design
Parallel
Treatments tested in this trial
Norepinephrine
DrugContinuous intravenous infusion of norepinephrine.
Treatment groups
Trial outcomes
Primary outcomes
Incidence of post-induction hypotension
Number of patients with mean arterial pressure drop greater than 20% from baseline or mean arterial pressure less than 65 mmHg within the first 30 minutes after induction of general anesthesia.
Secondary outcomes
Mean arterial pressure
Mean arterial pressure in mmHg.
Total dose of rescue vasopressors
Mean total dose of rescue vasopressors administered intraoperatively in micrograms.
Total volume of intravenous fluids
Mean total volume of intravenous fluids administered intraoperatively in milliliters.
Length of ICU stay
Mean length of intensive care unit stay in days.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: